Factors influencing results of chemotherapy in aggressive lymphomas.

被引：0
|
作者：
Souza, CA [1 ]
Moraes, SL [1 ]
Barbosa, KB [1 ]
Borba, G [1 ]
Regazzo, JT [1 ]
Neto, JPV [1 ]
LorandMetze, I [1 ]
机构：
[1] UNIV ESTADUAL CAMPINAS,DEPT INTERNAL MED,BR-13081970 CAMPINAS,SP,BRAZIL
来源：
BLOOD | 1996年 / 88卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3502 / 3502
页数：1
相关论文
共 50 条
  • [1] Mechanisms of Disease: Aggressive Lymphomas.
    Lenz, Georg
    Staudt, Louis M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (15): : 1417 - 1429
  • [2] Grey zone lymphomas. Limitations of the classification of aggressive B-cell lymphomas
    Ott, M. M.
    Horn, H.
    Rosenwald, A.
    Ott, G.
    PATHOLOGE, 2013, 34 (03): : 225 - 232
  • [3] RENAL INVOLVEMENT IN DIFFUSE AGGRESSIVE LYMPHOMAS - RESULTS OF TREATMENT WITH COMBINATION CHEMOTHERAPY
    GEFFEN, DB
    FISHER, RI
    LONGO, DL
    YOUNG, RC
    DEVITA, VT
    JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (05) : 646 - 653
  • [4] In vitro activity of SYK and BCR-ABL inhibitors in aggressive lymphomas.
    Bertoni, Francesco
    Rinaldi, Andrea
    Sasso, Anna
    Gaidano, Gianluca
    Zucca, Emanuele
    Uccella, Silvia
    Pruneri, Giancarlo
    Ponzoni, Maurilio
    Tibiletti, Maria Grazia
    Catapano, Carlo
    Cavalli, Franco
    BLOOD, 2006, 108 (11) : 713A - 713A
  • [5] FAILURE OF CONVENTIONAL CHEMOTHERAPY IN AGGRESSIVE LYMPHOMAS
    CUNNINGHAM, D
    HEPPLESTONE, A
    GILCHRIST, NL
    DAGG, JH
    EVANS, IL
    SOUKOP, M
    POSTGRADUATE MEDICAL JOURNAL, 1987, 63 (735) : 11 - 15
  • [6] THE ROLE OF CHEMOTHERAPY IN DIFFUSE AGGRESSIVE LYMPHOMAS
    DEVITA, VT
    HUBBARD, SM
    YOUNG, RC
    LONGO, DL
    SEMINARS IN HEMATOLOGY, 1988, 25 (02) : 2 - 10
  • [7] CHEMOTHERAPY FOR DIFFUSE AGGRESSIVE LYMPHOMAS - RESPONSE
    FISHER, RI
    DEVITA, VT
    HUBBARD, SM
    LONGO, DL
    WESLEY, R
    CHABNER, BA
    YOUNG, RC
    ANNALS OF INTERNAL MEDICINE, 1984, 101 (03) : 397 - 398
  • [8] STUDY OF TOXICITIES ASSOCIATED WITH THE R-DA-EPOCH CHEMOTHERAPY SCHEME IN THE FIRST LINE OF AGGRESSIVE LYMPHOMAS. UNICENTRIC COHORT
    Cruz Cruz, N.
    Gonzalvez Fernandez, J. A.
    Rodriguez Medina, C.
    Suarez Cabrera, A.
    Luzardo Henriquez, H.
    Torres Ochando, M. C.
    Perez Ortiz, L.
    De La Nuez Melian, H.
    Fernandez-Caldas Gonzalez, P.
    Gonzalez Pinedo, L.
    Acosta Fleitas, C.
    Borrero Borrego, A.
    Lopez Rodriguez, J. F.
    Perera Alvarez, M.
    Bravo de Laguna, S.
    Molero Labarta, T.
    HAEMATOLOGICA, 2019, 104 : 374 - 375
  • [9] Study of pegylated liposomal doxorubicin in first line therapy of aggressive lymphomas.
    Mandala, E
    Lafaras, C
    Ilonidis, G
    Venizelos, I
    Grollios, G
    Tsioni, C
    Bischiniotis, T
    Arvanitakis, C
    BLOOD, 2005, 106 (11) : 261B - 261B
  • [10] DEVEC metronomic schedule for aggressive B and T-cell lymphomas.
    Cox, Maria Christina
    Battistini, Roberta
    Pelliccia, Sabrina
    Arcari, Annalisa
    Borza, Paola Anticoli
    Casaroli, Ivana
    Zoli, Valerio
    Di Landro, Francesca
    Fabbri, Francesca
    Galassi, Giulia
    Leporace, Anna Paola
    Piedimonte, Monica
    Di Girolamo, Marco
    Prosperi, Daniela
    Campagna, Alessia
    Di Napoli, Arianna
    Tafuri, Agostino
    Bocci, Guido
    Musuraca, Gerardo
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345